- Home
- KARO vs GLPG Comparison
KARO vs GLPG Comparison
Compare KARO & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KARO
- GLPG
- Stock Information
- Founded
- KARO 2001
- GLPG 1999
- Country
- KARO Singapore
- GLPG Belgium
- Employees
- KARO N/A
- GLPG N/A
- Industry
- KARO Computer Software: Prepackaged Software
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- KARO Technology
- GLPG Health Care
- Exchange
- KARO Nasdaq
- GLPG Nasdaq
- Market Cap
- KARO 1.7B
- GLPG 1.9B
- IPO Year
- KARO 2021
- GLPG 2005
- Fundamental
- Price
- KARO $50.01
- GLPG $31.21
- Analyst Decision
- KARO Strong Buy
- GLPG Sell
- Analyst Count
- KARO 3
- GLPG 4
- Target Price
- KARO $57.00
- GLPG $25.33
- AVG Volume (30 Days)
- KARO 64.9K
- GLPG 222.2K
- Earning Date
- KARO 07-22-2025
- GLPG 07-23-2025
- Dividend Yield
- KARO 2.22%
- GLPG N/A
- EPS Growth
- KARO 24.98
- GLPG N/A
- EPS
- KARO 1.60
- GLPG N/A
- Revenue
- KARO $245,745,961.00
- GLPG $311,493,731.00
- Revenue This Year
- KARO $20.68
- GLPG $0.78
- Revenue Next Year
- KARO $15.64
- GLPG N/A
- P/E Ratio
- KARO $31.21
- GLPG N/A
- Revenue Growth
- KARO 8.61
- GLPG 18.32
- 52 Week Low
- KARO $28.04
- GLPG $22.36
- 52 Week High
- KARO $63.36
- GLPG $31.39
- Technical
- Relative Strength Index (RSI)
- KARO 51.13
- GLPG 70.92
- Support Level
- KARO $49.01
- GLPG $30.06
- Resistance Level
- KARO $51.99
- GLPG $30.78
- Average True Range (ATR)
- KARO 1.82
- GLPG 0.50
- MACD
- KARO 0.16
- GLPG 0.19
- Stochastic Oscillator
- KARO 64.31
- GLPG 99.10
About KARO Karooooo Ltd.
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.